Amikacin – (Amikacin, Amikin) POM

Download PDF
Prev1 of 3Next
Use your ← → (arrow) keys to browse

Amikacin - Iranian vet - DVM


Injectable: 50 mg/ml, 250 mg/ml solutions.


Action: Aminoglycosides inhibit bacterial protein synthesis. They are bactericidal and their mechanism of killing is concentration dependent, leading to a marked post-antibiotic effect, allowing prolonged dosing intervals (which may reduce toxicity).

Use: Active against many Gram-negative bacteria, Staphylococcus aureus and Nocardia spp., including some that may be resistant to gentamicin. Streptococci and anaerobes are usually resistant. Its use is only indicated after sensitivity testing has been performed and the organism shown to be resistant to other aminoglycosides such as gentamicin. Activity at low oxygen sites may be limited. Movement across biological membranes may also be limited, hence systemic levels require parenteral administration, and access to sites such as the CNS and ocular fluids is very limited. Monitoring serum amikacin levels should be considered to ensure therapeutic levels and minimize toxicity, particularly in neonates, geriatric patients and those with reduced renal function. Monitoring renal function is also advisable during treatment of any animal. Intravenous doses should be given slowly, generally over 30–60 min. Concurrent fluid therapy is advised.

Prev1 of 3Next
Use your ← → (arrow) keys to browse

, , , , , , , , , , , , , ,

No comments yet.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Powered by WordPress. Designed by WooThemes